These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 7542634)

  • 1. Humoral immunity to aerosolized staphylococcal enterotoxin B (SEB), a superantigen, in monkeys vaccinated with SEB toxoid-containing microspheres.
    Tseng J; Komisar JL; Trout RN; Hunt RE; Chen JY; Johnson AJ; Pitt L; Ruble DL
    Infect Immun; 1995 Aug; 63(8):2880-5. PubMed ID: 7542634
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunogenicity and efficacy against lethal aerosol staphylococcal enterotoxin B challenge in monkeys by intramuscular and respiratory delivery of proteosome-toxoid vaccines.
    Lowell GH; Colleton C; Frost D; Kaminski RW; Hughes M; Hatch J; Hooper C; Estep J; Pitt L; Topper M; Hunt RE; Baker W; Baze WB
    Infect Immun; 1996 Nov; 64(11):4686-93. PubMed ID: 8890226
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cellular and cytokine responses in the circulation and tissue reactions in the lung of rhesus monkeys (Macaca mulatta) pretreated with cyclosporin A and challenged with staphylococcal enterotoxin B.
    Komisar JL; Weng CF; Oyejide A; Hunt RE; Briscoe C; Tseng J
    Toxicol Pathol; 2001; 29(3):369-78. PubMed ID: 11442023
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunity and responses of circulating leukocytes and lymphocytes in monkeys to aerosolized staphylococcal enterotoxin B.
    Tseng J; Komisar JL; Chen JY; Hunt RE; Johnson AJ; Pitt L; Rivera J; Ruble DL; Trout R; Vega A
    Infect Immun; 1993 Feb; 61(2):391-8. PubMed ID: 8423069
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protection against bacterial superantigen staphylococcal enterotoxin B by passive vaccination.
    LeClaire RD; Hunt RE; Bavari S
    Infect Immun; 2002 May; 70(5):2278-81. PubMed ID: 11953360
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mucosal vaccination with recombinantly attenuated staphylococcal enterotoxin B and protection in a murine model.
    Stiles BG; Garza AR; Ulrich RG; Boles JW
    Infect Immun; 2001 Apr; 69(4):2031-6. PubMed ID: 11254555
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Generation of protective immunity by inactivated recombinant staphylococcal enterotoxin B vaccine in nonhuman primates and identification of correlates of immunity.
    Boles JW; Pitt ML; LeClaire RD; Gibbs PH; Torres E; Dyas B; Ulrich RG; Bavari S
    Clin Immunol; 2003 Jul; 108(1):51-9. PubMed ID: 12865071
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential effects of superantigen-induced "anergy" on priming and effector stages of a T cell-dependent antibody response.
    Lussow AR; MacDonald HR
    Eur J Immunol; 1994 Feb; 24(2):445-9. PubMed ID: 8299694
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biodegradable and biocompatible poly(DL-lactide-co-glycolide) microspheres as an adjuvant for staphylococcal enterotoxin B toxoid which enhances the level of toxin-neutralizing antibodies.
    Eldridge JH; Staas JK; Meulbroek JA; Tice TR; Gilley RM
    Infect Immun; 1991 Sep; 59(9):2978-86. PubMed ID: 1879922
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immediate responses of leukocytes, cytokines and glucocorticoid hormones in the blood circulation of monkeys following challenge with aerosolized staphylococcal enterotoxin B.
    Weng CF; Komisar JL; Hunt RE; Johnson AJ; Pitt ML; Ruble DL; Tseng J
    Int Immunol; 1997 Dec; 9(12):1825-36. PubMed ID: 9466310
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intranasal and intramuscular proteosome-staphylococcal enterotoxin B (SEB) toxoid vaccines: immunogenicity and efficacy against lethal SEB intoxication in mice.
    Lowell GH; Kaminski RW; Grate S; Hunt RE; Charney C; Zimmer S; Colleton C
    Infect Immun; 1996 May; 64(5):1706-13. PubMed ID: 8613381
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correlation of body temperature with protection against staphylococcal enterotoxin B exposure and use in determining vaccine dose-schedule.
    Boles JW; Pitt ML; LeClaire RD; Gibbs PH; Ulrich RG; Bavari S
    Vaccine; 2003 Jun; 21(21-22):2791-6. PubMed ID: 12798619
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Induction of interstitial pneumonia in autoimmune mice by intratracheal administration of superantigen staphylococcal enterotoxin B.
    Shinbori T; Matsuki M; Suga M; Kakimoto K; Ando M
    Cell Immunol; 1996 Dec; 174(2):129-37. PubMed ID: 8954612
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunity to aerosolized staphylococcal enterotoxin B.
    Tseng J; Komisar J; Chen JY; Hunt R; Johnson AJ; Pitt L; Ruble D
    Adv Exp Med Biol; 1995; 371B():1615-9. PubMed ID: 7502868
    [No Abstract]   [Full Text] [Related]  

  • 15. A novel staphylococcal enterotoxin B subunit vaccine candidate elicits protective immune response in a mouse model.
    Choi JY; Shin S; Kim NY; Son WS; Kang TJ; Song DH; Yu CH; Hur GH; Jeong ST; Shin YK
    Toxicon; 2017 Jun; 131():68-77. PubMed ID: 28359755
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acquired resistance to superantigen-induced T cell shock. V beta selective T cell unresponsiveness unfolds directly from a transient state of hyperreactivity.
    Miethke T; Wahl C; Heeg K; Wagner H
    J Immunol; 1993 May; 150(9):3776-84. PubMed ID: 8473732
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A highly neutralizing human monoclonal antibody targeting a novel linear epitope on staphylococcal enterotoxin B.
    Fan H; Zhao L; Wang W; Yu F; Jing H; Yang Y; Zhang X; Zhao Z; Gou Q; Zhang W; Zou Q; Zhang J; Zeng H
    Hum Vaccin Immunother; 2024 Dec; 20(1):2360338. PubMed ID: 38857905
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Staphylococcal enterotoxin B mutants (N23K and F44S): biological effects and vaccine potential in a mouse model.
    Woody MA; Krakauer T; Stiles BG
    Vaccine; 1997 Feb; 15(2):133-9. PubMed ID: 9066029
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chimeric anti-staphylococcal enterotoxin B antibodies and lovastatin act synergistically to provide in vivo protection against lethal doses of SEB.
    Tilahun ME; Kwan A; Natarajan K; Quinn M; Tilahun AY; Xie C; Margulies DH; Osborne BA; Goldsby RA; Rajagopalan G
    PLoS One; 2011; 6(11):e27203. PubMed ID: 22102880
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oral vaccine formulations stimulate mucosal and systemic antibody responses against staphylococcal enterotoxin B in a piglet model.
    Inskeep TK; Stahl C; Odle J; Oakes J; Hudson L; Bost KL; Piller KJ
    Clin Vaccine Immunol; 2010 Aug; 17(8):1163-9. PubMed ID: 20554806
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.